# Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer

> **NCT01627704** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 72 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Fluoroestradiol (18F)

## Key facts

- **NCT ID:** NCT01627704
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01627704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01627704, "Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01627704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*